• Chinese
  • English
  • Home
  • Gan & Lee Overview
    • Company Profile
    • Company Culture
    • Marketing Network
    • Member Companies
    • Strategic Partners
    • Gan & Lee History
    • Contact Us
  • Newsroom
    • Media Focus
    • Company News
    • Industry News
    • Honors and Awards
    • International Business
  • Products
    • Insulin Analogue
    • Medical Devices
  • R&D
    • Intellectual Property
  • Social Responsibility
    • Diabetes and Insulin
  • Careers
    • Why choose Gan & Lee
    • What we are looking for
    • What we can offer
    • Join us
  • GDPR POLICY
    • GDPR FOR CHINA
    • GDPR FOR USA
Gan & Lee Overview
  • Company Profile
  • Company Culture
  • Marketing Network
  • Member Companies
  • Strategic Partners
  • Gan & Lee History
  • Contact Us
    • Inquiry
    • Business Contact Business Collaboration
    • Contact information

Fast Track

Gan & Lee History

  • Home
  • Gan & Lee Overview
  • Gan & Lee History
  • 2011-03-28The company completed financing with other investors
  • 2010-03-27The company completed first round financing from Ming Hua Technology Investment (HK) Limited
  • 2007-01-30Gan & Lee launched Prandilin®
  • 2007-01-28Received Prandilin® GMP certificate from the SFDA
  • 2006-01-28Received production approval document for Prandilin® from the SFDA
  • 2005-10-28Basalin® entered the international market, including Egypt, Pakistan, South East Asia and Latin America
  • <<
  • 1
  • 2
  • 3
  • >>

Copyright @ 2016 Gan & Lee Pharmaceuticals. All rights reserved.